Avopef

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 83831-145
  • Package NDC 83831-145-25
  • Application number NDA220200
  • SPL ID d2f8949c-2fc5-46c5-befb-f03cbb80d59e
  • SPL set ID acc1e443-ef7b-486f-a638-710a20e81059
  • UNII 6PLQ3CP4P3
  • RxCUI 310248
  • RxCUI 2735802

What the source publishes

Labeler
AVYXA Pharma, LLC
Active ingredients
etoposide
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:83831-145_d2f8949c-2fc5-46c5-befb-f03cbb80d59e
{
  "name": "Avopef",
  "splId": "d2f8949c-2fc5-46c5-befb-f03cbb80d59e",
  "labels": [
    {
      "setId": "acc1e443-ef7b-486f-a638-710a20e81059",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acc1e443-ef7b-486f-a638-710a20e81059",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acc1e443-ef7b-486f-a638-710a20e81059"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "AVYXA Pharma, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL in 1 CARTON (83831-145-25)  / 25 mL in 1 VIAL",
      "package_ndc": "83831-145-25",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260914"
    }
  ],
  "productId": "83831-145_d2f8949c-2fc5-46c5-befb-f03cbb80d59e",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "83831-145",
  "deaSchedule": null,
  "genericName": "etoposide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ETOPOSIDE",
      "strength": "500 mg/25mL"
    }
  ],
  "applicationNumber": "NDA220200",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260914",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175609",
      "N0000000176"
    ],
    "upc": [
      "0383831145257"
    ],
    "unii": [
      "6PLQ3CP4P3"
    ],
    "rxcui": [
      "310248",
      "2735802"
    ],
    "spl_set_id": [
      "acc1e443-ef7b-486f-a638-710a20e81059"
    ],
    "pharm_class_epc": [
      "Topoisomerase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Topoisomerase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "AVYXA Pharma, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:83831-145_d2f8949c-2fc5-46c5-befb-f03cbb80d59e"